WallStreetZenWallStreetZen

NASDAQ: ISPC
Ispecimen Inc Stock

Overview
EarningsRevenueDividendOwnership
$1.27+0.04 (+3.25%)
Updated Apr 30, 2025
ISPC Price
$1.27
Fair Value Price
N/A
Market Cap
$3.17M
52 Week Low
$1.02
52 Week High
$11.80
P/E
-0.07x
P/B
0.96x
P/S
0.2x
PEG
N/A
Dividend Yield
N/A
Revenue
$9.29M
Earnings
-$12.50M
Gross Margin
42.9%
Operating Margin
-132.64%
Profit Margin
-134.5%
Debt to Equity
1.82
Operating Cash Flow
-$8M
Beta
0.78
Next Earnings
May 22, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ISPC Overview

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide through its iSpecimen Market placplatform. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen was incorporated in 2009 and is headquartered in Lexington, MA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ISPC's potential to beat the market

View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
B
ISPC
RankedUnranked of 44

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Illumina (ILMN)
$77.60A
Qiagen Nv (QGEN)
$42.75A
Mettler Toledo International (MTD)
$1,070.57B
View Top Diagnostic & Research Stocks

Be the first to know about important ISPC news, forecast changes, insider trades & much more!

ISPC News

Overview

Due Diligence Score

–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ISPC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ISPC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ISPC is good value based on its book value relative to its share price (0.96x), compared to the US Diagnostics & Research industry average (3.39x)
P/B vs Industry Valuation
ISPC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ISPC due diligence checks available for Premium users.

Valuation

ISPC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.07x
Industry
39.05x
Market
29.18x

ISPC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.96x
Industry
3.39x
ISPC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ISPC's financial health

Profit margin

Revenue
$1.5M
Net Income
-$6.0M
Profit Margin
-409.8%
ISPC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ISPC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$9.4M
Liabilities
$6.0M
Debt to equity
1.82
ISPC's short-term liabilities ($5.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ISPC's short-term assets ($3.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ISPC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ISPC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.6M
Investing
-$73.1k
Financing
$3.8M
ISPC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ISPC vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ISPC–$3.17M+3.25%-0.07x0.96x
NDRA–$3.38M+0.17%-0.11x1.32x
XWEL–$4.00M-7.31%-0.21x-5.08x
CHEK–$4.51M+7.69%-0.36x0.26x
APDNC$974.63k-1.89%-0.00x0.08x
View Top Diagnostic & Research Stocks

Ispecimen Stock FAQ

What is Ispecimen's quote symbol?

(NASDAQ: ISPC) Ispecimen trades on the NASDAQ under the ticker symbol ISPC. Ispecimen stock quotes can also be displayed as NASDAQ: ISPC.

If you're new to stock investing, here's how to buy Ispecimen stock.

What is the 52 week high and low for Ispecimen (NASDAQ: ISPC)?

(NASDAQ: ISPC) Ispecimen's 52-week high was $11.80, and its 52-week low was $1.02. It is currently -89.24% from its 52-week high and 24.51% from its 52-week low.

How much is Ispecimen stock worth today?

(NASDAQ: ISPC) Ispecimen currently has 2,496,858 outstanding shares. With Ispecimen stock trading at $1.27 per share, the total value of Ispecimen stock (market capitalization) is $3.17M.

Ispecimen stock was originally listed at a price of $143.00 in Jun 17, 2021. If you had invested in Ispecimen stock at $143.00, your return over the last 3 years would have been -99.11%, for an annualized return of -79.29% (not including any dividends or dividend reinvestments).

How much is Ispecimen's stock price per share?

(NASDAQ: ISPC) Ispecimen stock price per share is $1.27 today (as of Apr 30, 2025).

What is Ispecimen's Market Cap?

(NASDAQ: ISPC) Ispecimen's market cap is $3.17M, as of May 1, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ispecimen's market cap is calculated by multiplying ISPC's current stock price of $1.27 by ISPC's total outstanding shares of 2,496,858.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.